Literature DB >> 18515170

Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease.

C-A Haensch1, H Lerch, J Jörg, S Isenmann.   

Abstract

Patients with idiopathic Parkinson's disease (PD) have impaired sympathetically mediated neurocirculatory innervation. Here we analyzed the correlation between cardiac (123)I-metaiodobenzylguanidine (MIBG) uptake, orthostatic hypotension and heart rate variability in treated patients with PD. Orthostatic hypotension (OH) as a hallmark of sympathetic neurocirculatory failure was found with a high prevalence in PD. PD is known to affect cardiac innervation, resulting in a suppressed heart rate variability and a postganglionic noradrenergic lesion. We measured continuous arterial blood pressure in rest and 70 degrees head-up tilt for at least 20 min, heart rate variability in the supine position, standing, deep respiration and Valsalva manoeuvre in 58 patients with PD (27 male, 31 female; mean age 71 years, mean PD duration 5.1 years, Hoehn and Yahr 3.1+/-0.8). Sympathovagal balance was estimated by the low-frequency (LF: 0.04-0.15Hz) and high-frequency bands (HF: 0.15-0.4Hz) ratio in the analysis of heart rate variability in each condition. Myocardial adrenergic function was analyzed by imaging MIBG using the single-photon emission computed tomography technique. MIBG uptake expressed as heart-to-mediastinum ratio was reduced in all PD patients (H/M-ratio: 1.14+/-0.16). We found no correlation between myocardial MIBG uptake and sympathovagal balance, blood pressure or other autonomic findings. The LF/HF ratio in tilt-table testing was significantly more reduced in PD with OH than without OH (2.18 vs. 1.49, p=0.022). MIBG uptake did not differ. It is concluded that scintigraphy with MIBG appears to be a highly sensitive and useful tool to demonstrate sympathetic postganglionic cardiac nerve disturbances. Loss of sympathetic innervation of the heart seems to occur early and independent of orthostatic hypotension, baroreflex failure and impaired heart rate variability in PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18515170     DOI: 10.1016/j.parkreldis.2008.04.031

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  27 in total

1.  Low frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation.

Authors:  Faisal Rahman; Sandra Pechnik; Daniel Gross; LaToya Sewell; David S Goldstein
Journal:  Clin Auton Res       Date:  2011-01-29       Impact factor: 4.435

2.  Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease.

Authors:  Hisayoshi Oka; Chizuko Toyoda; Makiko Yogo; Soichiro Mochio
Journal:  J Neurol       Date:  2010-01-30       Impact factor: 4.849

3.  Olfactory dysfunction and parasympathetic dysautonomia in Parkinson's disease.

Authors:  Peter Kang; John Kloke; Samay Jain
Journal:  Clin Auton Res       Date:  2012-08       Impact factor: 4.435

4.  Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Authors:  T Pérez; B Tijero; I Gabilondo; A Luna; V Llorens; K Berganzo; M Acera; A Gonzalez; A Sanchez-Ferro; E Lezcano; J J Zarranz; J C Gómez-Esteban
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

Review 5.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

Review 6.  Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Daan C Velseboer; Rob J de Haan; Wouter Wieling; David S Goldstein; Rob M A de Bie
Journal:  Parkinsonism Relat Disord       Date:  2011-05-14       Impact factor: 4.891

7.  Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods.

Authors:  Omar Asghar; Parthiban Arumugam; Ian Armstrong; Simon Ray; Matthias Schmitt; Rayaz A Malik
Journal:  Nucl Med Commun       Date:  2017-01       Impact factor: 1.690

8.  Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.

Authors:  Masashi Suzuki; Tomohiko Nakamura; Masaaki Hirayama; Miki Ueda; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2016-11-29       Impact factor: 4.849

9.  Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease.

Authors:  Hisayoshi Oka; Chizuko Toyoda; Makiko Yogo; Soichiro Mochio
Journal:  J Neural Transm (Vienna)       Date:  2011-02-18       Impact factor: 3.575

10.  Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.

Authors:  Trine Gjerløff; Tatyana Fedorova; Karoline Knudsen; Ole L Munk; Adjmal Nahimi; Steen Jacobsen; Erik H Danielsen; Astrid J Terkelsen; John Hansen; Nicola Pavese; David J Brooks; Per Borghammer
Journal:  Brain       Date:  2014-12-23       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.